Medicus Pharma (MDCX) Change in Accured Expenses (2024 - 2025)
Medicus Pharma's (MDCX) quarterly Change in Accured Expenses came in at -$549969.0 in Q4 2025, down 560.26% YoY from $119492.0 in Q4 2024, and up 42.37% on a QoQ basis from -$954308.0 in Q3 2025.
Medicus Pharma (MDCX) Change in Accured Expenses (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Change in Accured Expenses data on file, last reported at -$549969.0 in Q4 2025.
- Quarterly Change in Accured Expenses fell 560.26% year-over-year to -$549969.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$438802.0 (down 222.56% YoY) and the FY2025 annual result came in at -$438802.0, down 222.56% from the prior year.
- Change in Accured Expenses rose to -$549969.0 in Q4 2025, from -$954308.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $766272.0 in Q2 2025 to a low of -$954308.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 852.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 338.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -549,969.00 |
| Dec 31, 2025 | -549,969.00 |
| Sep 30, 2025 | -954,308.00 |
| Sep 30, 2025 | -954,308.00 |
| Jun 30, 2025 | 766,272.00 |
| Jun 30, 2025 | 766,272.00 |
| Mar 31, 2025 | 299,203.00 |
| Mar 31, 2025 | 299,203.00 |
| Dec 31, 2024 | 119,492.00 |
| Dec 31, 2024 | 119,492.00 |
| Sep 30, 2024 | 23,829.00 |
| Sep 30, 2024 | 23,829.00 |
| Jun 30, 2024 | 224,354.00 |
| Jun 30, 2024 | 224,354.00 |
| Mar 31, 2024 | -9,657.00 |
| Mar 31, 2024 | -9,657.00 |